InvestSMART

Amaero Ltd (ASX:3DA)

ALERT: Price-sensitive ASX Announcement for 3DA
Current share price for 3DA : $0.175 -0.045 (-20.45%)+
Announcement
Release
19 Aug 2026 8:29AM
Price at Release
$0.220
Full Release
download
Summary
The document is the Appendix 4E and Audited Financial Report for Memphasys Limited, covering the financial year ending 30 June 2025. The report outlines a significant decrease in revenue from continuing ordinary activities by 94% to $4,000, while total income decreased by 47% to $532,000. The net loss attributable to members increased by 11% to $4,942,913. The report highlights that the group has a net tangible liability per ordinary security of (0.2) cents, and their accumulated losses have increased from $50,430,086 in 2024 to $55,247,604 in 2025. The financial statements are in the process of being audited, and no significant events affecting the group's operations have occurred since the end of the financial year. The report also details the principal activities of the company, which include developing and commercializing reproduction and fertility solutions, particularly focusing on the Felix™ System aimed at male fertility.
Key Points
  • Revenue decreased by 94% to $4,000.
  • Total income from continuing activities decreased by 47% to $532,000.
  • Net loss attributable to members increased by 11% to $4,942,913.
  • Net tangible liability per ordinary security is (0.2) cents.
  • Accumulated losses increased to $55,247,604.
  • Financial statements are undergoing an audit.
  • Focus on developing the Felix™ System for male fertility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.